7 results
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... of with Community-Acquired ... fluoroquinolone #IDSA ... #Community #Acquired ... Management #Guidelines #pharmacology
Antibiotic treatment durations for first line antibiotics recommended by Public Health England (PHE) guidance
 • Acute
Antibiotic treatment ... acquired pneumonia ... and CRB65=1 7-10 ... #primarycare #outpatient ... #treatment #pharmacology
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Toxic Megacolon, Shock ... Epidemiology: • #1 ... post-ABx, but can be community-acquired ... Ileus, Megacolon, Shock ... 10 mg/kg IV x 1
CSF Penetration of Antimicrobials

Despite the poor CSF penetration, beta-lactams have the most research documenting successful treatment
of community-acquired ... antibiotic classes. 1 ... infections 3 overcome ... of CNS infections ... InfectiousDiseases #Pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 4–6 mL QID or 1– ... antifungals are required ... opportunistic #infections ... #HIVAIDS #pharmacology
Community Acquired Pneumonia (CAP) - Diagnosis and Management

Pneumonia Signs/Symptoms:
 • Confusion/disorientation (LR + 1.9)
 • Cough
Community Acquired ... chest pain (LR + NS ... Egophony (May appear 1- ... ranging from 2% (outpatients ... #Pulmonary #Community
IDSA Recommendations for Treating Bartonella Infections in HIV-AIDS
Preferred Therapy
For Bacillary Angiomatosis, Peliosis Hepatis, Bacteremia, and Osteomyelitis:
IDSA Recommendations ... Involving the CNS ... q12h + gentamicin 1 ... Bartonellosis #IDSA ... #HIVAIDS #pharmacology